Á lódáil...
Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial
BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...
Na minha lista:
Foilsithe in: | Nephrol Dial Transplant |
---|---|
Main Authors: | , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Oxford University Press
2016
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4725389/ https://ncbi.nlm.nih.gov/pubmed/26429974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv346 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|